Skip to content
Triangle logo TriangleGet started
← Full study record

NCT02860286 · OUTCOME

Part 1: To Assess Disease Control Rate (DCR) Defined as Number of Subjects With Complete Response (CR), Partial Response (PR) and Stable Disease (SD)

Study of the EZH2 Inhibitor Tazemetostat in Malignant Mesothelioma · Source last updated 2021-04-09

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
COUNT_OF_PARTICIPANTS
Unit
Participants
Interval / dispersion
Not reported
Time frame
The patients were assessed for DCR for up to 24 weeks

What was measured

Overall, the disease control rate (DCR) (calculated as subjects with CR + subjects with PR + subjects with SD at 12 weeks in duration), and the DCR at 24 weeks.

Groups in this outcome

Part

Subjects with relapsed or refractory malignant mesothelioma regardless of BAP1 status

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Part13

Reported measurements

DCR at 12 weeks
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Part5Not reportedNot reportedNot reportedNot reported
DCR at 24 weeks
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Part1Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        5
    title
    DCR at 12 weeks
  2. categories
    1. measurements
      1. group Id
        OG000
        value
        1
    title
    DCR at 24 weeks
denoms
  1. counts
    1. group Id
      OG000
      value
      13
    units
    Participants
description
Overall, the disease control rate (DCR) (calculated as subjects with CR + subjects with PR + subjects with SD at 12 weeks in duration), and the DCR at 24 weeks.
groups
  1. description
    Subjects with relapsed or refractory malignant mesothelioma regardless of BAP1 status
    id
    OG000
    title
    Part
param Type
COUNT_OF_PARTICIPANTS
reporting Status
POSTED
time Frame
The patients were assessed for DCR for up to 24 weeks
title
Part 1: To Assess Disease Control Rate (DCR) Defined as Number of Subjects With Complete Response (CR), Partial Response (PR) and Stable Disease (SD)
type
SECONDARY
unit Of Measure
Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice